DIAGNOS Inc. (DGNOF)
OTCMKTS · Delayed Price · Currency is USD
0.2425
+0.0138 (6.05%)
Oct 24, 2025, 3:25 PM EDT
DIAGNOS Market Cap
DIAGNOS has a market cap or net worth of $25.35 million as of October 24, 2025. Its market cap has increased by 18.70% in one year.
Market Cap
25.35M
Enterprise Value
25.95M
Revenue
63.43K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.24
Market Cap Chart
Since November 30, 2000, DIAGNOS's market cap has increased from 24.36M to 25.35M, an increase of 4.08%. That is a compound annual growth rate of 0.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 25.35M | 34.53% |
| Dec 31, 2024 | 18.85M | -17.35% |
| Dec 29, 2023 | 22.80M | 58.65% |
| Dec 30, 2022 | 14.37M | -22.60% |
| Dec 31, 2021 | 18.57M | -38.89% |
| Dec 31, 2020 | 30.39M | 319.61% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 806.69M |
| Elite Pharmaceuticals | 670.91M |
| Glass House Brands | 619.92M |
| Northwest Biotherapeutics | 371.21M |
| Silence Therapeutics | 344.81M |
| Nika Pharmaceuticals | 335.28M |
| CytoDyn | 327.16M |
| American Oncology Network | 291.52M |